Dimethylformamide → HCID 178522790, 화합물
반응식
C[Si](C)(C)CCOC[N:7]1[C:11]2=[N:12][CH:13]=[CH:14][CH:15]=[C:10]2[C:9]([C:16]2[S:20][C:19]([CH2:21][NH2:22])=[CH:18][CH:17]=2)=[N:8]1.[F:25][C:26]1[CH:27]=[C:28]([CH:40]=[CH:41][C:42]=1[F:43])[CH2:29][N:30]1[CH:35]=[CH:34][CH:33]=[C:32]([C:36](O)=[O:37])[C:31]1=[O:39].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CN(C)C=O.C(N(CC)C(C)C)(C)C>C(O)(=O)CC(CC(O)=O)(C(O)=O)O.O>[NH:7]1[C:11]2=[N:12][CH:13]=[CH:14][CH:15]=[C:10]2[C:9]([C:16]2[S:20][C:19]([CH2:21][NH:22][C:36]([C:32]3[C:31](=[O:39])[N:30]([CH2:29][C:28]4[CH:40]=[CH:41][C:42]([F:43])=[C:26]([F:25])[CH:27]=4)[CH:35]=[CH:34][CH:33]=3)=[O:37])=[CH:18][CH:17]=2)=[N:8]1참가 물질
반응물 5
생성물 1
시약·촉매·용매 2
실험 절차
C-{5-[1-(2-Trimethylsilanyl-ethoxymethyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-thiophen-2-yl}-methylamine (23 mg, 0.000064 mol), 1-(3,4-difluoro-benzyl)-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid (2.0E1 mg, 0.000075 mol) and HATU (44 mg, 0.00012 mol; Applied Biosystems) were dissolved in N,N-dimethylformamide (1.25 mL, 0.0161 mol; Acros). To this was added N,N-diisopropylethylamine (56 uL, 0.00032 mol; Aldrich) and the reaction was stirred for 1 hour at room temperature. The reaction was diluted with 5% citric acid in water, then extracted with ethyl acetate. Saturated sodium chloride was added to aid separation. The organic layer was washed with saturated sodium chloride, dried with sodium sulfate, filtered and evaporated to yield the crude title compound. MS m/z=608.34 (M+1).
후처리
- extractionextracted with ethyl acetate
- additionSaturated sodium chloride was added
- customseparation
- washThe organic layer was washed with saturated sodium chloride
- dry with materialdried with sodium sulfate
- filtrationfiltered
- customevaporated
출처 및 근거
- ORD 기록
- ord-9c8ecf8a04804a4db8f630c4134e98b2
- 출처 데이터셋
- uspto-grants-2014_07
- 특허 번호
- US08778977B2
반응 노트
불러오는 중…